SCHEMBL4768787

SCHEMBL4768787

O=C(O)C(=CO)c1cccc(Br)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 1/20 0.55
PARP1 P09874 1/20 0.53
ALDH1A1 P00352 5/20 0.47
TP53 P04637 1/20 0.47
MAPT P10636 4/20 0.46
HPGD P15428 2/20 0.45
AKR1C3 P42330 1/20 0.44
AKR1C2 P52895 1/20 0.44
C1S P09871 1/20 0.44
SMN1; SMN2 Q16637 4/20 0.44
GAA P10253 1/20 0.44
NFKB1 P19838 1/20 0.44
NFKB2 Q00653 1/20 0.44
RELA Q04206 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
LMNA P02545 1/20 0.43
HTT P42858 1/20 0.43
CYP19A1 P11511 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4768785 1.00 PTGS2 (0.55) PTGS2PARP1ALDH1A1TP53MAPT
SCHEMBL5206467 0.81 PTGS2 (0.70) PTGS2PARP1ALDH1A1MAPTHPGD
SCHEMBL30522332 0.81 PTGS2 (0.55) PTGS2PARP1ALDH1A1TP53MAPT
SCHEMBL8795911 0.81 PTGS2 (0.70) PTGS2PARP1ALDH1A1MAPTHPGD
SCHEMBL2582001 0.80 PTGS2 (0.53) PTGS2PARP1ALDH1A1TP53MAPT
SCHEMBL2582000 0.80 PTGS2 (0.53) PTGS2PARP1ALDH1A1TP53MAPT
SCHEMBL10367778 0.78 CES2 (0.57) PARP1HPGDAKR1C3AKR1C2SMN1; SMN2
SCHEMBL3069399 0.78 AKR1C1 (0.61) PTGS2PARP1ALDH1A1MAPTHPGD
SCHEMBL6474719 0.78 AKR1C1 (0.61) PTGS2PARP1ALDH1A1MAPTHPGD
SCHEMBL2383745 0.77 CYP19A1 (0.48) PTGS2PARP1ALDH1A1MAPTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1742947-B1 6-SUBSTITUTED PYRIDOINDOLONE DERIVATIVES PRODUCTION AND THERAPEUTIC USE THEREOF SANOFI AVENTIS (FR) 2008-08-20 EP disclosed
EP-1556382-B1 3-PHENYL SUBSTITUTED PYRIDOINDOLONE, PREPARATION AND THERAPEUTIC USE THEREOF SANOFI AVENTIS (FR) 2008-05-28 EP disclosed
EP-1742947-A1 6-SUBSTITUTED PYRIDOINDOLONE DERIVATIVES PRODUCTION AND THERAPEUTIC USE THEREOF Sanofi-Aventis (FR) 2007-01-17 EP disclosed
WO-2005108398-A1 6-SUBSTITUTED PYRIDOINDOLONE DERIVATIVES PRODUCTION AND THERAPEUTIC USE THEREOF SANOFI-AVENTIS (FR) 2005-11-17 WO disclosed
EP-1556382-A1 3-PHENYL SUBSTITUTED PYRIDOINDOLONE, PREPARATION AND THERAPEUTIC USE THEREOF Sanofi-Aventis (FR) 2005-07-27 EP disclosed
WO-2004041817-A1 3-PHENYL SUBSTITUTED PYRIDOINDOLONE, PREPARATION AND THERAPEUTIC USE THEREOF SANOFI-AVENTIS (FR) 2004-05-21 WO disclosed